Morgan Stanley reiterates Affirm stock Overweight rating on valuation By Investing.com

Morgan Stanley reiterated an Overweight rating on Affirm Holdings with a $76 price target, implying 26% upside from $60.28 and about 24x fiscal 2028 EPS. The firm cited stable ABS spreads, continued funding availability, and potential upside from the company’s Investor Forum raising GMV, margin, and EPS targets. Sentiment is mixed overall given competing analyst views, but the latest call remains constructive for AFRM.

Analysis

AFRM is being rerated not because the near-term setup is pristine, but because the market is still pricing the wrong regime. If funding remains open and ABS clears steadily, the key second-order effect is operating leverage: even modest GMV beats can flow through disproportionately as credit provisioning normalizes and fixed-cost growth slows. That makes the upcoming guidepost event more important than the current quarter, since a credible multi-year target reset can force sell-side models higher in a hurry.

The biggest winner may actually be the stock’s multiple, not the business itself. At this valuation, the market is still assigning a quasi-distress premium to consumer-credit exposure; if management demonstrates that warehouse/ABS liquidity is stable through a choppy macro tape, the bear case loses its anchor. Conversely, if spreads widen meaningfully or any funding window tightens, the downside is abrupt because the equity is effectively a long-duration call on lender confidence.

Consensus appears to be underestimating how asymmetric the next 1-2 catalysts are. A raised outlook would likely compress the narrative gap between AFRM and higher-quality fintech lenders, while a merely “okay” update could disappoint because the bar has shifted upward after the recent analyst stack-up. The trade is not about proving pristine credit; it is about proving that credit is manageable enough for EPS power to reassert itself over the next 6-12 months.

Key Decisions for Investors

• Go long AFRM into the Investor Forum with a 4-8 week horizon; use the event as the catalyst window for estimate revisions and a 15-25% rerating if guidance lifts.
• For a cleaner expression of funding-risk relief, pair long AFRM / short a basket of regional credit-sensitive fintechs over 1-3 months; AFRM should outperform if ABS markets stay stable while peers remain range-bound.
• If you want convexity, buy AFRM calls 1-2 expiries out rather than stock; the stock can reprice sharply on a guidance reset, but downside is capped to premium if credit chatter returns.
• Tactically trim only on a post-event gap if the stock moves above the high-$70s without a raise in targets; that would be the point where upside becomes more execution-dependent than narrative-driven.
• Avoid shorting into the event unless ABS spreads materially widen; the risk/reward is poor because any stable-funding confirmation could force a fast short-covering move.